サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1609806

日本のニューロモデュレーション市場レポート：技術、バイオマテリアル、用途、地域別、2024年～2032年

Japan Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 117 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
日本のニューロモデュレーション市場レポート：技術、バイオマテリアル、用途、地域別、2024年～2032年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 117 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のニューロモデュレーション市場の市場規模は2023年に3億820万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに9億2,550万米ドルに達し、2024年から2032年の間に13.30%の成長率（CAGR）を示すと予測しています。日本における高齢者人口の増加、最近の技術的進歩、ヘルスケア支出の増加、ニューロモデュレーションの利点に関する意識の高まり、主要市場プレイヤーの強力なプレゼンス、有利な償還政策の導入などが市場を牽引する主な要因です。

本レポートで扱う主な質問

  • 日本のニューロモデュレーション市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19の日本のニューロモデュレーション市場への影響は？
  • 日本のニューロモデュレーション市場の技術別の内訳は？
  • 日本のニューロモデュレーション市場のバイオマテリアル別の内訳は？
  • 日本のニューロモデュレーション市場の用途別の内訳は？
  • 日本のニューロモデュレーション市場のバリューチェーンにはどのような段階があるか？
  • 日本のニューロモデュレーションの主な促進要因と課題は何か？
  • 日本のニューロモデュレーション市場の構造と主要プレーヤーは？
  • 日本のニューロモデュレーション市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のニューロモデュレーション市場：イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本のニューロモデュレーション市場情勢

  • 過去および現在の市場動向（2018～2023年）
  • 市場予測（2024～2032年）

第6章 日本のニューロモデュレーション市場：技術別の内訳

  • 内部ニューロモデュレーション
  • 外部ニューロモデュレーション

第7章 日本のニューロモデュレーション市場：バイオマテリアル別の内訳

  • 金属バイオマテリアル
  • 高分子バイオマテリアル
  • セラミックバイオマテリアル

第8章 日本のニューロモデュレーション市場：用途別の内訳

  • パーキンソン病
  • てんかん
  • うつ
  • ジストニア
  • 疼痛管理
  • その他

第9章 日本のニューロモデュレーション市場：競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第10章 主要企業のプロファイル

第11章 日本のニューロモデュレーション市場：業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第12章 付録

目次
Product Code: SR112024A19378

Japan neuromodulation market size reached US$ 308.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 925.5 Million by 2032, exhibiting a growth rate (CAGR) of 13.30% during 2024-2032. The rising geriatric population in Japan, recent technological advancements, increasing healthcare expenditure, heightened awareness about the benefits of neuromodulation, strong presence of key market players, and introduction of favorable reimbursement policies represent some of the key factors driving the market.

Neuromodulation refers to a technology involving the modification of nerve activity by delivering pharmaceutical or electrical agents to targeted areas of the nervous system. It encompasses a wide range of types, including spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, and peripheral nerve stimulation. Neuromodulation is comprised of several components, such as a pulse generator, electrodes, and a handheld device for programming. It offers multiple features, including minimally invasive procedures, customizable treatment settings, and real-time feedback mechanisms. Neuromodulation is widely used for treating chronic pain, epilepsy, movement disorders, psychiatric conditions, migraines, and gastrointestinal issues. It offers targeted therapy, reduced side effects as compared to systemic drug administration, reversibility, and the potential for remote patient monitoring. Additionally, neuromodulation provides several advantages, such as enhanced patient compliance, better quality of life, cost-effectiveness in the long run, and the opportunity for real-time adjustments to treatment settings.

Japan Neuromodulation Market Trends:

The rising geriatric population in Japan, contributing to the escalating incidences of neurological and chronic disorders, is propelling the market growth. Additionally, recent technological advancements, such as the advent of wireless neuromodulation, that are expanding the technique's applications are driving the market growth. Besides this, the increasing healthcare spending and the prioritization of neurological research, fostering a conducive environment for market expansion, is acting as another growth-inducing factor. Furthermore, the heightened awareness about the benefits of neuromodulation, which is facilitating faster adoption rates, is catalyzing the market growth. In addition to this, the strong presence of key market players and frequent product launches in Japan is stimulating the market growth. Apart from this, the introduction of favorable reimbursement policies by the government healthcare system for neuromodulation procedures is bolstering the market growth. Moreover, the growing evidence of the efficacy of neuromodulation through clinical trials, lending further credence to the technology, is positively influencing the market growth. Along with this, the widespread demand for minimally invasive procedures, boosting neuromodulation applications, is supporting the market growth. In line with this, the escalating number of skilled healthcare professionals in the field of neuromodulation is driving the market growth. Furthermore, the integration of artificial intelligence (AI) for real-time adjustments and monitoring is creating a positive outlook for the market growth. In addition, the rising patient compliance and satisfaction rates with neuromodulation, encouraging more referrals, is accelerating the market growth. Besides this, the increasing strategic collaborations and acquisitions among key players to expand further research and leverage shared expertise are strengthening the market growth. Additionally, the growing public and private investment in research and development (R&D) activities is fueling the market growth.

Japan Neuromodulation Market Segmentation:

Technology Insights:

  • Internal Neuromodulation
  • Spinal Cord Stimulation (SCS)
  • Deep Brain Stimulation (DBS)
  • Vagus Nerve Stimulation (VNS)
  • Sacral Nerve Stimulation (SNS)
  • Gastric Electrical Stimulation (GES)
  • External Neuromodulation
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Transcranial Magnetic Stimulation (TMS)
  • Others

Biomaterial Insights:

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials

Application Insights:

  • Parkinson's Disease
  • Epilepsy
  • Depression
  • Dystonia
  • Pain Management
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan neuromodulation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan neuromodulation market?
  • What is the breakup of the Japan neuromodulation market on the basis of technology?
  • What is the breakup of the Japan neuromodulation market on the basis of biomaterial?
  • What is the breakup of the Japan neuromodulation market on the basis of application?
  • What are the various stages in the value chain of the Japan neuromodulation market?
  • What are the key driving factors and challenges in the Japan neuromodulation?
  • What is the structure of the Japan neuromodulation market and who are the key players?
  • What is the degree of competition in the Japan neuromodulation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Neuromodulation Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Neuromodulation Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Neuromodulation Market - Breakup by Technology

  • 6.1 Internal Neuromodulation
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Spinal Cord Stimulation (SCS)
      • 6.1.3.2 Deep Brain Stimulation (DBS)
      • 6.1.3.3 Vagus Nerve Stimulation (VNS)
      • 6.1.3.4 Sacral Nerve Stimulation (SNS)
      • 6.1.3.5 Gastric Electrical Stimulation (GES)
    • 6.1.4 Market Forecast (2024-2032)
  • 6.2 External Neuromodulation
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 6.2.3.2 Transcranial Magnetic Stimulation (TMS)
      • 6.2.3.3 Others
    • 6.2.4 Market Forecast (2024-2032)

7 Japan Neuromodulation Market - Breakup by Biomaterial

  • 7.1 Metallic Biomaterials
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Polymeric Biomaterials
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Ceramic Biomaterials
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)

8 Japan Neuromodulation Market - Breakup by Application

  • 8.1 Parkinson's Disease
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Epilepsy
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Depression
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)
  • 8.4 Dystonia
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2018-2023)
    • 8.4.3 Market Forecast (2024-2032)
  • 8.5 Pain Management
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2018-2023)
    • 8.5.3 Market Forecast (2024-2032)
  • 8.6 Others
    • 8.6.1 Historical and Current Market Trends (2018-2023)
    • 8.6.2 Market Forecast (2024-2032)

9 Japan Neuromodulation Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Neuromodulation Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix